PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

In recent years, immunotherapies, such as those involving chimeric antigen receptor (CAR) T cells, have become increasingly promising approaches to non-small-cell lung cancer (NSCLC) treatment. In this study, we explored the antitumor potential of prostate stem cell antigen (PSCA)-redirected CAR T a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncoimmunology
Glavni autori: Wei, Xinru, Lai, Yunxin, Li, Jin, Qin, Le, Xu, Youdi, Zhao, Ruocong, Li, Baiheng, Lin, Simiao, Wang, Suna, Wu, Qiting, Liang, Qiubin, Peng, Muyun, Yu, Fenglei, Li, Yangqiu, Zhang, Xuchao, Wu, Yilong, Liu, Pentao, Pei, Duanqing, Yao, Yao, Li, Peng
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384358/
https://ncbi.nlm.nih.gov/pubmed/28405515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1284722
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items